Tracheal aspirate presepsin: a promising biomarker in early onset neonatal pneumonia

References

• Wormser GP, Goldfarb J. Infectious diseases of the fetus and newborn, 5th Edition. Clin Infect Dis. 2001;33(3):417–418.
   Google Scholar
• Nissen MD. Congenital and neonatal pneumonia. Paediatr Respir Rev. 2007;8:195–203.
   PubMed Web of Science ®Google Scholar
• Duke T. Neonatal pneumonia in developing countries. Arch Dis Child Fetal Neonatal Ed. 2005;90:211–219.
   PubMed Web of Science ®Google Scholar
• Black RE, Cousens S, Johnson HL, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet. 2010;375:1969–1987.
   PubMed Web of Science ®Google Scholar
• Bersani I, Auriti C, Ronchetti MP, et al. Use of early biomarkers in neonatal brain damage and sepsis: state of the art and future perspectives. Biomed Res Int. 2015;2015:1–10.
   Web of Science ®Google Scholar
• Booth GR, Al-Hosni M, Ali A, et al. The utility of tracheal aspirate cultures in the immediate neonatal period. J Perinatol. 2009;29(7):493–496.
   PubMed Web of Science ®Google Scholar
• Sherman MP, Goetzman BW, Ahlfors CE, et al. Tracheal aspiration and its clinical correlates in the diagnosis of congenital pneumonia. Pediatrics. 1980;65(2):258–263.
   PubMed Web of Science ®Google Scholar
• Webber S, Wilkinson AR, Lindsell D, et al. Neonatal pneumonia. Arch Dis Child. 1990;65:207– 211.
   PubMed Web of Science ®Google Scholar
• Labib M, Berezovski MV. Electrochemical aptasensors for microbial and viral pathogens. Adv Biochem Eng Biotechnol. 2014;140:155–181.
   PubMed Web of Science ®Google Scholar
• Alizadeh N, Memar MY, Moaddab SR, et al. Aptamer-assisted novel technologies for detecting bacterial pathogens. Biomed Pharmacother. 2017;93:737–745.
   PubMed Web of Science ®Google Scholar
• Leli C, Ferranti M, Marrano U, et al. Diagnostic accuracy of presepsin (sCD14-ST) and procalcitonin for prediction of bacteraemia and bacterial DNAaemia in patients with suspected sepsis. J Med Microbiol. 2016;65(8):713–719.
   PubMedGoogle Scholar
• Memar MY, Varshochi M, Shokouhi B, et al. Procalcitonin: the marker of pediatric bacterial infection. Biomed Pharmacother. 2017;96:936–943.
   PubMed Web of Science ®Google Scholar
• Memar MY, Alizadeh N, Varshochi M, et al. Immunologic biomarkers for diagnostic of early-onset neonatal sepsis. J Matern Neonatal Med. 2019;32(1):143–153.
   PubMed Web of Science ®Google Scholar
• Sandquist M, Wong HR. Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment. Expert Rev Clin Immunol. 2014;10:1349–1356.
   PubMed Web of Science ®Google Scholar
• Wu CC, Lan HM, Han ST, et al. Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C-reactive protein: a systematic review and meta-analysis. Ann Intensive Care. 2017;7:91.
   PubMed Web of Science ®Google Scholar
• Marcos V, Latzin P, Hector A, et al. Expression, regulation and clinical significance of soluble and membrane CD14 receptors in pediatric inflammatory lung diseases. Respir Res. 2010;11:32.
   PubMed Web of Science ®Google Scholar
• Puri KS, Suresh KR, Gogtay NJ, et al. Declaration of Helsinki, 2008: implications for stakeholders in research. J Postgrad Med. 2009;55:131–134.
   PubMed Web of Science ®Google Scholar
• Sankar MJ, Sankar J, Agarwal R, etal. Protocol for administering continuous positive airway pressure in neonates. Indian J Pediatr. 2008;75:471–478.
   PubMed Web of Science ®Google Scholar
• Mathur NB, Garg K, Kumar S. Respiratory distress in neonates with special reference to pneumonia. Indian Pediatr. 2002;39:529–537.
   PubMedGoogle Scholar
• Pugni L, Pietrasanta C, Milani S, et al. Presepsin [soluble CD14 subtype], reference ranges of a new sepsis marker in term and preterm neonates. PLoS One. 2015;10:12.
   Web of Science ®Google Scholar
• Morsy AA, Elshall LY, Zaher MM, etal. CD64 cell surface expression on neutrophils for diagnosis of neonatal sepsis. Egypt J Immunol. 2008;15:53–61.
   PubMedGoogle Scholar
• Hooven TA, Polin RA. Pneumonia. Semin Fetal Neonatal Med. 2017;22:206–2013.
   PubMed Web of Science ®Google Scholar
• Hofer N, Zacharias E, Müller W, et al. An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology. 2012;102:25–36.
   PubMed Web of Science ®Google Scholar
• Mathai E, Christopher U, Mathai M, et al. Is C-reactive protein level useful in differentiating infected from uninfected neonates among those at risk of infection? Indian Pediatr. 2004;41:895–900.
   PubMedGoogle Scholar
• Chiesa C, Natale F, Pascone R, et al. C reactive protein and procalcitonin: reference intervals for preterm and term newborns during the early neonatal period. Clin Chim Acta. 2011; 412:1053–1059.
   PubMed Web of Science ®Google Scholar
• Mussap M, Noto A, Cibecchini F, et al. The importance of biomarkers in neonatology. Semin Fetal Neonatal Med. 2013;18(1):56–64.
   PubMed Web of Science ®Google Scholar
• Meem M, Modak JK, Mortuza R, et al. Biomarkers for diagnosis of neonatal infections: a systematic analysis of their potential as a point-of-care diagnostics. J Glob Health. 2011;1:201–209.
   PubMedGoogle Scholar
• Bozkaya D, Yiğit Ş, Yurdakök M. Is serum procalcitonin level a reliable indicator in early diagnosis of congenital pneumonia? Turk J Pediatr. 2019;61(1):34–39.
   PubMed Web of Science ®Google Scholar
• Mussap M, Degrandi R, Cataldi L, et al. Biochemical markers for the early assessment of neonatal sepsis: the role of procalcitonin. J Chemother. 2007;19(sup2):35–38.
   PubMedGoogle Scholar
• Shozushima T, Takahashi G, Matsumoto N, etal. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother. 2011;17:764–769.
   PubMed Web of Science ®Google Scholar
• Hashem HE, Abdel Halim RM, El Masry SA, et al. The utility of neutrophil CD64 and presepsin as diagnostic, prognostic, and monitoring biomarkers in neonatal sepsis. Int. J. Microbiol. 2020; 2020:1–13.
   Web of Science ®Google Scholar
• Savić D, Simović A, Marković S, et al. The role of presepsin obtained from tracheal aspirates in the diagnosis of early onset pneumonia in intubated newborns. Indian J Pediatr. 2018;85(11):968–973.
   PubMed Web of Science ®Google Scholar
• Montaldo P, Rosso R, Santantonio A, et al. Presepsin for the detection of early-onset sepsis in preterm newborns. Pediatr Res. 2017;81(2):329–334.
   PubMed Web of Science ®Google Scholar
• Klouche K, Cristol JP, Devin J, et al. Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients. Ann Intensive Care. 2016;6:59.
   PubMed Web of Science ®Google Scholar
• Masson S, Caironi P, Fanizza C, et al. Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial. Intensive Care Med. 2015;41(1):12–20.
   PubMed Web of Science ®Google Scholar
• Arai Y, Mizugishi K, Nonomura K, et al. Phagocytosis by human monocytes is required for the secretion of presepsin. J Infect Chemother. 2015;21:564–569.
   PubMed Web of Science ®Google Scholar